• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Graft Versus Host Disease (GVHD) 
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for GVHD trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing GVHD research

The medical research community has made significant strides in understanding the pathophysiology behind graft versus host disease (GVHD), but work remains in terms of discovering effective treatment options. Leverage our Signant SmartSignals end-to-end solutions as well as our in-house expertise in rare disorders to address research challenges.

GVHD-1

Why Signant Health

  • Capture Better PRO Data
  • Work With GVHD Experts
  • Conduct Study Activities Remotely
  • Maximize Supplies Efficiency
  • Make It Easier to Participate
  • Capture Better PRO Data

    Capture Better PRO Data

    Most GVHD protocols include several site- or home-based patient-reported outcome measures such as the Lee GVHD Symptom Scale. The Signant SmartSignals eCOA platform digitalizes the PRO experience to improve data quality and reduce patient burdens. Built-in prompts and engagement features ensure assessments are completed on-time and with fewer errors compared to pencil-and-paper capture methods.
     

  • Work With GVHD Experts

    Work With GVHD Experts

    With decades of clinical science experience, our GVHD research leaders are prepared to serve as an extension of your study team. Rely on our in-house neurology experts to help optimize GVHD protocols, implement clinically-appropriate instruments, and oversee data quality from launch through regulatory submission.
     

  • Conduct Study Activities Remotely

    Conduct Study Activities Remotely

    Reach participants where they are by offering solutions that facilitate remote study activities. Signant's comprehensive range of solutions, global project teams, and international regulatory know-how will help you conduct trial activities anywhere and any way. Our clinical science team provides guidance and oversight to optimize remote study operations.
     

  • Maximize Supplies Efficiency

    Maximize Supplies Efficiency

    Take control of inventory management complexities and simplify randomization for multi-arm trial designs with Signant's global RTSM solution. Study teams trust our solution to not only launch studies faster but to handle patient cohorts, study supply forecasting, and data transfers with efficiency and accuracy.
     

  • Make It Easier to Participate

    Make It Easier to Participate

    Simplify the clinical trial experience for patients and sites alike by providing tools like eConsent and Telemedicine. These solutions help reduce unnecessary site visits, improve remote collaboration between sites and patients, and ensure protocol adherence.
     

Comprehensive GVHD experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our GVHD trial resources
SOLUTION BROCHURE

GVHD Trial Solutions Overview


GET INSIGHTS
VIDEO

GVHD Trial Solutions



WATCH [2 MIN]
SOLUTION

Telemedicine



LEARN MORE

eClinical solutions for GVHD trials

Ready to learn more?

Discover how Signant can support your current or upcoming GVHD trials. 

DOWNLOAD BROCHURE GET STARTED